Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) was the target of a significant drop in short interest during the month of September. As of September 15th, there was short interest totaling 204 shares, a drop of 85.7% from the August 31st total of 1,431 shares. Based on an average daily volume of 631 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the shares of the stock are sold short.
Orion OYJ Price Performance
Shares of OTCMKTS:ORINY traded up $0.52 on Friday, reaching $47.67. The company’s stock had a trading volume of 198 shares, compared to its average volume of 231. The company has a 50-day simple moving average of $44.48 and a 200 day simple moving average of $40.64. Orion OYJ has a 52-week low of $30.89 and a 52-week high of $47.67. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.48 and a current ratio of 2.64. The company has a market cap of $13.46 billion, a P/E ratio of 19.62 and a beta of 0.08.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last announced its earnings results on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The firm had revenue of $606.38 million for the quarter. Orion OYJ had a net margin of 28.52% and a return on equity of 50.37%.
About Orion OYJ
Orion Oyj is a Finland-based pharmaceutical company that develops, manufactures and markets human and veterinary medicines. Its portfolio includes proprietary prescription treatments, generic medicines, consumer health products and pharmaceutical active ingredients.
The company focuses its research and commercial activities on areas including central nervous system disorders, oncology, respiratory diseases, veterinary medicine and pain management. Orion also works with international pharmaceutical companies through licensing, development and commercialization partnerships.
Founded in 1917, Orion is headquartered in Espoo, Finland, and serves customers through operations and partnerships in Finland, Europe and other international markets.
Featured Stories
- Five stocks we like better than Orion OYJ
- 3 More AI Infrastructure Plays Beyond the Big Names
- CAVA Stock Slips: Sector Fear or Valuation Reality?
- Why Equal-Weight Funds Hide A Yield Curve Catch
- 5 Scary-Good Stocks With Strong October Catalysts and Breakout Potential
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
